Slanicka Krieger M, Nissen C, Manz C Y, Toksoz D, Lyman S D, Wodnar-Filipowicz A
Research Department, University Hospital Basel, Switzerland.
Exp Hematol. 1998 May;26(5):365-73.
The hematopoietic growth factors stem cell factor (SCF) and flt3 ligand (flt3L) are produced within the hematopoietic microenvironment in a membrane-bound and soluble isoform. To elucidate the relevance of the two isoforms in the network of early-acting cytokines, we examined the interaction of membrane-bound SCF with the soluble forms of SCF and flt3L in long-term cultures of human bone marrow cells. Feeder layers of the murine SCF-deficient Steel stromal cell line transfected with human cDNA stably expressing SCF as a transmembrane molecule were used to support growth of mononuclear cells and CD34+ progenitors derived from normal human bone marrow or from hypoplastic marrow of patients with aplastic anemia (AA). The output of nonadherent progenitor cells representing colony-forming units (CFU) and high-proliferative potential colony-forming cells (HPP-CFC) was scored weekly in secondary methylcellulose cultures; the number of colonies derived from long-term culture-initiating cells (LTC-IC) was determined in nonadherent and adherent cells at 5 weeks. Membrane-bound SCF expressed in the stromal layer was more effective than soluble SCF and soluble flt3L in maintaining clonogenic progenitors. Furthermore, the transmembrane form of SCF effectively synergized with both exogenously supplied factors, although the effect of flt3L was superior to the effect of soluble SCF. In cultures of normal bone marrow cells, addition of flt3L enhanced the total number of CFU and HPP-CFC-type progenitors, primarily of the granulocyte/macrophage lineage, by six- to ninefold after 3 weeks and of LTC-IC-derived colonies by 13-fold after 5 weeks of culture. In cultures of AA cells, both the number and the survival rate of clonogenic precursors were severely impaired even in the presence of flt3L, which, however, yielded a two- to sixfold enhancement of CFU and HPP-CFC numbers at 1 to 2 weeks. In comparison with the hematopoietic function of human Dexter-type stroma cultures, murine feeders expressing high levels of membrane-associated human SCF were equivalent in supporting hematopoiesis during the initial 3 to 4 culture weeks when supplemented with flt3L. These results demonstrate that soluble flt3L interacts with membrane-bound SCF in supporting the long-term growth of bone marrow progenitor cells. The hypothesis that SCF and flt3L function synergistically during the very early stages of human hematopoiesis is thereby reinforced.
造血生长因子干细胞因子(SCF)和fms样酪氨酸激酶3配体(flt3L)以膜结合型和可溶性异构体形式在造血微环境中产生。为了阐明这两种异构体在早期作用细胞因子网络中的相关性,我们在人骨髓细胞的长期培养中研究了膜结合型SCF与SCF和flt3L可溶性形式的相互作用。用稳定表达作为跨膜分子的SCF的人cDNA转染的小鼠SCF缺陷型Steel基质细胞系的饲养层,用于支持源自正常人骨髓或再生障碍性贫血(AA)患者增生低下骨髓的单核细胞和CD34 +祖细胞的生长。在二次甲基纤维素培养中每周对代表集落形成单位(CFU)和高增殖潜能集落形成细胞(HPP-CFC)的非贴壁祖细胞产量进行评分;在5周时测定非贴壁和贴壁细胞中源自长期培养起始细胞(LTC-IC)的集落数量。基质层中表达的膜结合型SCF在维持克隆性祖细胞方面比可溶性SCF和可溶性flt3L更有效。此外,SCF的跨膜形式与两种外源性供应因子均有效协同作用,尽管flt3L的作用优于可溶性SCF。在正常骨髓细胞培养中,添加flt之后3周,3L使CFU和HPP-CFC型祖细胞的总数增加了6至9倍,主要是粒细胞/巨噬细胞系,培养5周后,LTC-IC衍生集落增加了13倍。在AA细胞培养中,即使存在flt3L,克隆前体细胞的数量和存活率也严重受损,然而,在1至2周时,CFU和HPP-CFC数量增加了2至6倍。与人类德克斯特型基质培养的造血功能相比,表达高水平膜相关人SCF的小鼠饲养层在补充flt3L的最初3至4个培养周期间在支持造血方面相当。这些结果表明,可溶性flt3L与膜结合型SCF相互作用以支持骨髓祖细胞的长期生长。从而加强了SCF和flt3L在人类造血非常早期阶段协同发挥作用的假说。